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The human immunodeficiency virus type I (HIV-1) encodes 
three structural (gag, pol and env), four accessory (vif, vpr, vpu 
and nef ) and two regulatory (tat and rev) genes, the products of 
which are responsible for establishing sophisticated interactions 
between the virus and human host. HIV-1 transcriptional activa-
tor (Tat) is a small (~11 kDa) basic protein that binds to the trans-
activation-response element (TAR) on the nascent viral RNA 
and recruits molecular components for efficient transcriptional 
elongation.1 Thus, Tat displays an array of functions that are 
essential for viral gene expression and replication, but also affects 
host gene expression.2 Tat is an early regulatory protein that has a 
variable length of 86–103 aa (depending on viral isolates) and is 
encoded by two exons. The first exon encodes the first 72 amino 
acids and the second exon encodes for the remaining residues. 
Tat is actively released by infected T-cells into the extracellular 
medium by an unconventional mechanism3,4 and the concen-
tration of Tat in the serum of HIV-1 infected patients reaches 
nanomolar levels.5 Tat can cross the blood brain barrier6,7 and 
be produced in situ by HIV-1 infected cells such as perivascular 
macrophages, astrocytes and microglia. Tat is thus present within 
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the central nervous system and could potentially be involved in 
HIV-1 neuropathogenesis. HIV-1-associated neuronal symptoms 
include motor or cognitive dysfunctions and behavioral changes 
affecting nearly one third of patients undergoing intensive tri-
therapy. Moreover, one patient out of ten develops HIV-1 associ-
ated dementia at the late stage of AIDS.8 Although some signs of 
neuronal death have been reported in these patients, they most 
likely do not explain the extent of cognitive alterations, suggest-
ing alternative unknown mechanism altering neuronal functions.
Extracellular Tat has been shown to penetrate several cell 
types through different pathways9 and the capacity of Tat to 
reach the cytosol of uninfected cells likely enables circulating Tat 
to interfere with key cellular processes in these cells. Moreover, 
the recent breakthrough identifying the membrane inner leaf-
let phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P
2
] as a 
high affinity ligand for Tat,10 suggests that key cellular activities 
relying on PtdIns(4,5)P
2
 such as exocytosis might be affected in 
neurosecreting cells.
In our efforts to unravel the potential effect of Tat on neuro-
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A2 plays an essential role in calcium-regulated exocytosis by 
promoting the formation of exocytotic platforms in neuroen-
docrine cells.15,16 Inhibition of annexin A2 translocation in cells 
exposed to Tat led to a reduction in the number of functional 
exocytotic sites and to a concomitant decrease in the number of 
exocytotic events.14 Furthermore, we found that Tat hampers 
the actin cytoskeleton reorganization during neurosecretion, an 
effect that may also be a direct consequence of Tat binding to 
PtdIns(4,5)P
2
. Indeed, available PtdIns(4,5)P
2
 can be a limiting 
factor for exocytosis efficacy since it orchestrates the actin-medi-
ated movements of secretory granules to exocytotic sites.17 In chro-
maffin cells, the cortical F-actin network constitutes a negative 
clamp preventing the movement of secretory vesicles to release 
sites, and it must be locally disassembled and reorganized in a 
PtdIns(4,5)P
2
-dependent manner to allow recruitment of secre-
tory vesicles in preparation for exocytosis.18 Thus, the inhibi-
tory effect of Tat on subplasmalemmal actin may also explain 
its capacity to impair the exocytotic response.
In our attempt to decipher the mechanism(s) by which Tat 
alters PtdIns(4,5)P
2
-dependent membrane trafficking processes 
in neurosecretory cells, we explored the ability of Tat to directly 
affect PtdIns(4,5)P
2
 metabolism. Indeed, the quantity of avail-
able PtdIns(4,5)P
2
 can influence the efficacy of exocytotic pro-
cess. PtdIns(4,5)P
2
 synthesis and hydrolysis is regulated by a 
complex set of inositol kinases, lipases and phosphatases, includ-
ing PtdIns(4,5)P
2
-specific phospholipase C (PLC). PtdIns(4,5)P
2
 
hydrolysis by PLC generates two second messengers, namely dia-
cylglycerol (DAG) and inositol 1,4,5-trisphosphate, which both 
play a major role in neuronal plasticity and exocytosis.19
To examine whether Tat interferes with the production of 
second messengers through hydrolysis of PtdIns(4,5)P
2
 by PLC 
during exocytosis, we monitored DAG production in PC12 cells 
in situ upon neurosecretion stimulation. To this end, cells were 
transfected with a high affinity DAG sensor using the tandem C1 
domains (C1ab) of protein kinase D tagged with GFP at the C 
terminus (pKDC1ab-GFP).20 This probe enables to track the in 
situ production of DAG from PtdIns(4,5)P
2
 upon ATP stimula-
tion, used here as a secretagogue to trigger exocytosis.
In resting PC12 cells, we found that pKDC1ab-GFP mostly 
localized in the cytoplasm and in perinuclear Golgi-like struc-
tures, but also weakly in the nucleus of some cells. Indeed, 
pKDC1ab-GFP possesses a nuclear export signal at the N termi-
nus of the probe that may influence its nuclear accumulation.20 
Cell stimulation induced a dramatic and transient recruitment 
of pKDC1ab-GFP to the cell periphery (Fig. 1, upper panel), 
revealing the rapid and robust production of DAG at the plasma 
membrane of stimulated PC12 cells. Image quantification indi-
cated that recruitment of the DAG probe to the plasma mem-
brane peaked between 20 sec and 40 sec after stimulation and 
thereafter decreased to reach basal level 3 min after stimulation 
(Fig. 2). In cells exposed to exogenous Tat, the translocation of 
the DAG sensor to the plasma membrane in response to secreta-
gogue stimulation was significantly delayed reaching a plateau 
only 200 sec after stimulation (Fig. 1, middle panel and Fig. 
2). Interestingly, the highest fluorescence intensity reached at 
the plasma membrane in Tat-treated cells was similar to that 
conventional neurosecretory cell models i.e., chromaffin and 
PC12 cells.11 Consistent with the Tat uptake pathway observed 
in other cell types,12,13 our results indicate that internalized Tat is 
first found in early endosomal structures, as revealed by co-local-
ization with EEA1 and then in late endo-lysosomal Lamp-1 posi-
tive structures.14 After 4 h, Tat-containing vesicular structures 
were barely detectable and, concomitantly, Tat signal became 
visible on the inner leaflet of the plasma membrane.14 In addi-
tion, when overexpressed in PC12 cells, Tat localized essentially 
at the plasma membrane.14 The binding of Tat to PtdIns(4,5)P
2
 
is largely responsible for this recruitment of Tat to the plasma 





 5-phosphatases, which reduce cellular 
PtdIns(4,5)P
2
 levels when overexpressed, efficiently displaced Tat 
from the plasma membrane to the cytosol.14
Most strikingly, once internalized by chromaffin and 
PC12 cells, Tat strongly inhibited the number of exocytotic 
events as revealed by a reduction in amperometric spike fre-
quency and growth hormone release, respectively.14 Inhibition 
of secretion was observed at nanomolar concentrations of 
Tat, comparable with the concentrations reported for circu-
lating Tat,5 thereby arguing for the physiological significance 
of our findings. Expression of Tat mutants unable to bind 
PtdIns(4,5)P
2
 did not inhibit secretion, demonstrating that the 
effect of Tat on secretion is directly linked to its interaction with 
PtdIns(4,5)P
2
 at the plasma membrane and does not result 
from a transcriptional effect of Tat.14 Overexpression of 
phosphatidylinositol 4 phosphate 5-kinase was able to par-
tially rescue secretion from cells exposed to Tat, in line 
with the idea that Tat blocks secretion through its capac-
ity to specifically bind PtdIns(4,5)P
2
. Interaction of Tat with 
PtdIns(4,5)P
2
 occurs with such a high affinity that Tat seques-
ters this phosphoinositide and thereby strongly impairs the 
translocation of the PtdIns(4,5)P
2
-binding protein annexin A2 
to the plasma membrane following cell stimulation. Annexin 
Figure 1. HIV-1 Tat perturbs the recruitment to the plasma membrane 
of a DAG biosensor in PC12 cells stimulated for exocytosis. Cells express-
ing a fluorescent DAG probe were incubated 2 h with neomycin (4 mM) 
or treated with Tat (50 nM, 30 min 0°C, then chased for 4 h) at 37°C 
before exocytosis stimulation using 300 μM ATP. Pictures extracted 
from a representative video of each condition show the distribution of 
the pKDC1ab-GFP in control (i.e., vehicle), Tat or neomycin treated cells 
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DAG biosensor (pKDC1ab-GFP) recruitment to the plasma 
membrane of PC12 cells was recorded using a SP5II Leica confo-
cal microscope in xyt mode using a 63X oil-immersion objective 
and a heated stage (37°C). Recordings were started 45 sec before 
cell stimulation, and a total of 601 frames were taken at every 500 
ms during 5 min.
Data and image analysis. The recruitment of GFP tagged 
DAG biosensor was analyzed using the SP5II Leica quantifica-
tion software (LAS AF Lite). Three regions of interest (ROI) 
were determined to delimitate cell periphery including plasma 
membrane, cytoplasm and nucleus of each cell. Average fluores-
cence intensities of different ROIs were analyzed through the 601 
frames of recorded videos for each condition. Time dependent 
variation of fluorescence intensities at plasma membrane level 
and cytoplasm is expressed as mean ± SEM. Values are normal-
ized to starting point fluorescence intensities that are fixed as 
100%. Data were generated from 8 control, 8 Tat-treated and 
5 neomycin-treated cells respectively issued from two indepen-
dent cell cultures. Statistical significance was estimated using 
Student’s t-test and data were considered significantly different 
when p < 0.01. Gaussian distribution of the data was verified.
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in control cells. Thus, the total level of DAG production was 
similar in Tat-treated and control cells, but with strikingly dif-
ferent kinetics. DAG generation was rapid and transient in con-
trol cells whereas it increased slowly and progressively in cells 
exposed to Tat (Fig. 2). In Tat-treated cells the DAG probe 
remained recruited at the plasma membrane for up to 8 min 
and subsequently slowly translocated back to the cytoplasm 
(not shown).
To test the idea that Tat may affect PLC activity by reducing 
substrate [PtdIns(4,5)P
2
] availability, we tested the effect of neo-
mycin, a non-specific PLC inhibitor known to prevent DAG pro-
duction by sequestering PtdIns(4,5)P
2
. As illustrated in Figure 
1 (lower panel), neomycin treatment (4 mM for 2 h) completely 
blocked the recruitment of the DAG probe to the plasma mem-
brane in response to exocytosis stimulation. This result suggests 
that neomycin and Tat affect DAG production through dis-
tinct mechanisms in ATP stimulated PC12 cells that undergo 
exocytosis. Hence, Tat may be progressively displaced from 
PtdIns(4,5)P
2
 allowing its slow hydrolysis by PLC or Tat might 
be able to directly affect the enzymatic activity of PLC. The latest 
possibility is however unlikely because we recently reported that 
Tat has no impact on the fast and transient calcium increase in 
PC12 cells undergoing exocytosis,14 which reflects normal PLC 
activity in these cells under these conditions. An alternative pos-
sibility is that in the presence of Tat, the cell differently handles 
DAG. It is noteworthy to mention that DAG can be transformed 
into phosphatidic acid (PA) by DAG-kinase. On the other hand 
PA itself, which is produced at exocytotic sites in neurosecreting 
cells,21 can also be converted into DAG by PA phosphohydrolase. 
This PA phosphohydrolase activity, as an alternative pathway in 
these cells, might thus be responsible for some of the lately pro-
duced DAG explaining the delay in the pKDC1ab-GFP probe 
recruitment to the plasma membrane. It is likely that precise lipi-
domic analyzes will be required to fully understand the profound 
effect of Tat on lipid turnover in neurosecretory cells.
In conclusion, we found that Tat dramatically inhibited 
neurosecretion by a mechanism that most likely reflects a gen-
eral alteration of the availability and/or the metabolism of 
PtdIns(4,5)P
2
. These effects of Tat might contribute to the neu-
ronal disorders associated with HIV-1 infection.
Materials and Methods
Cell culture, transfection and imaging. PC12 cells were cultured 
as described previously22 and transfected with pKDC1ab-GFP 
expression vector (0.8 to 1 μg total DNA, 15 × 104 cells, 24-well 
plate) using Lipofectamine 2000 as previously reported.23 Under 
these conditions, transfection efficiency was around 50%.
Twenty-four h after transfection, PC12 cells were treated 2 
h with 4 mM neomycin or incubated for 30 min on ice with 
50 nM Tat or citrate buffer (vehicle, 100 mM NaCl, 50 mM 
Na-citrate, pH 7) and chased for 4 h at 37°C as described.14 Cells 
were then washed three times with Locke’s buffer (140 mM 
NaCl, 4.7 mM KCl, 2.5 mM CaCl
2
, 1.2 mM MgSO
4
, 11 mM 
glucose and 15 mM HEPES, pH 7.4) and stimulated with 300 
μM ATP in Locke’s buffer24 to trigger exocytosis. GFP-tagged 
Figure 2. Tat modifies the DAG biosensor translocation kinetics to the 
plasma membrane in PC12 cells stimulated for exocytosis. Intensi-
ties of fluorescence of the DAG probe were quantified in each video 
frame. The plots show the time-dependent increase of fluorescence at 
the plasma membrane and the concomitant decrease of signal in the 
cytoplasm in control (ctrl), Tat-treated (Tat) and neomycin-treated (neo) 
cells. Arrow indicates exocytosis stimulation (at 45 sec of the record-
ings). Mean values ± s.e.m. obtained from 8 (Tat-treated or control) or 5 
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